MedPath

Efficacy check of hair care products

Not Applicable
Registration Number
CTRI/2023/12/060610
Lead Sponsor
SATIYA NUTRACEUTICALS PRIVATE LIMITED
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)Indian male & female subjects.

2)Healthy subjects

3)Skin & scalp is healthy on the studied anatomic unit

4) Having moderate to severe hair fall

Exclusion Criteria

1)Being insulin-dependent diabetic or non insulin-dependent diabetic with a recent therapy (less than 6 months)

2) Having a progressive asthma (either under treatment or last fit in the last 2 years)

3) Being epileptic

4) Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months)

5) Having cutaneous hypersensitivity

6) Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products

7) Following a chronic or intermittent medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, anti-coagulants, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol)

8) Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months

9) Having changed his/her cosmetic habits except those required by the protocol in the 14 days preceding the start of the study on the studied anatomic unit.

10) Having applied a hair care product and cosmetic product on the studied area as well as on the face the first day of the study (except the neutral shampoo without anti hairfall claim or hair growth claim)

11)Having naturally fair or white hair (Which will interfere the evaluation)

12)Having a dermatosis on the scalp

13)Having surgery history on the scalp (micro transplants)

14)Refusing the bleaching of two areas of the scalp of approx. 40 hairs, the first day of the study.

15)Refusing the pluking of approx. 10 hairs, during the entire study

16)Having presented a factor inducing a telogen effluvium in the 3 months preceding the start of the study (delivery, important stress, high fever)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in hair fallTimepoint: Baseline, 14 days, 28 days
Secondary Outcome Measures
NameTimeMethod
ilTimepoint: NA
© Copyright 2025. All Rights Reserved by MedPath